Kyle Van Noy
Edge Rusher
Age: 29
Free Agency: 2024 (UFA)
Accrued Seasons: 6
- Height: 6-3
- Weight: 245
- College: BYU
- Entry: 2014 Draft, Round 2, #40 overall (Lions)
- 2020 Salary Cap Charge: $10,900,000 (5.01% of cap)
- 2020 Cash Payout: $15,025,000 (6.70% of spending)
- 2020 Cash to Cap Ratio: 1.38
- Contract Value: $51,000,000 ($12,750,000 APY)
- Fully Guaranteed Money: $15,000,000
- Contract Ranking: 23/227 at EDGE
Current Contract
(UFA, signed 2020)
(📝: indicates contract trigger occuring during that year)| Year | Age | Base Salary | Prorated Bonus | Roster Bonus | Workout Bonus | Guaranteed Salary | Cap Number | Cap % | Dead Money & Cap Savings | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 29 | $3,000,000 | $1,375,000 | $6,500,000 | $25,000 | $9,500,000 | $10,900,000 | 5.0% | |||||
| 2021
March 22: Base salary becomes guaranteed
| 30 | $12,500,000 | $1,375,000 | $0 | $25,000 | $0 | $13,900,000 | 6.5% | |||||
| 2022
March 22: $2.5 million becomes guaranteed
| 31 | $12,250,000 | $1,375,000 | $0 | $25,000 | $0 | $13,650,000 | 6.0% | |||||
| 2023 | 32 | $11,150,000 | $1,375,000 | $0 | $25,000 | $0 | $12,550,000 | 5.2% | |||||
| Total | $38,900,000 | $5,500,000 | $6,500,000 | $100,000 | $9,500,000 | $51,000,000 | |||||||
Contract Notes
Kyle Van Noy signed a four year, $51 million contract with the Dolphins. $15 million is fully guaranteed at signing including a $5.5 million signing bonus. Another $15 million is guaranteed for injury. If Van Noy is on the roster on the 5th day of the 2021 league year he $12.5 million salary will become guaranteed. If on the roster on the 5th day of the 2022 league year another $2.5 million of salary is guaranteed.Career Earnings: $21,289,644
Career APY: $3,548,274
Potential Earnings: $66,789,644
Total Guarantees: $26,605,068
Largest Cash Payment: $15,025,000 (2020)
Largest Cap Number: $13,900,000 (2021)
Contract History
| Team | Contract Type | Status | Year Signed | Yrs | Total | APY | Guarantees | Amount Earned | % Earned | Effective APY |
|---|---|---|---|---|---|---|---|---|---|---|
| Lions | Drafted | Traded | 2014 | 4 | $5,102,103 | $1,275,526 | $3,052,534 | $3,102,534 | 60.8% | $1,551,267 |
| Patriots | Drafted | Renegotiated | 2014 | 4 | $5,102,103 | $1,275,526 | $3,052,534 | $446,369 | 8.7% | $446,369 |
| Patriots | Extension | Expired | 2017 | 2 | $10,750,000 | $5,375,000 | $5,500,000 | $12,240,741 | 113.9% | $4,080,247 |
| Dolphins | UFA | Active | 2020 | 4 | $51,000,000 | $12,750,000 | $15,000,000 | $5,500,000 | 10.8% | $0 |
Earnings By Team
| Team | Yrs | Salary | APY | Paid on Cap | % Paid on Cap | Paid as Dead Money | % Paid as Dead Money |
|---|---|---|---|---|---|---|---|
| Lions | 2 | $3,102,534 | $1,551,267 | $2,087,224 | 0.0% | $1,452,769 | 0.0% |
| Patriots | 4 | $12,687,110 | $3,171,778 | $12,593,360 | 0.0% | $0 | 0.0% |
| Dolphins | 0 | $5,500,000 | $0 | $0 | 0.0% | $0 | 0.0% |
Salary Cap History
| Year | Team | Base Salary | Prorated Bonus | Roster Bonus | Per Game Roster Bonus | Workout Bonus | Other Bonus | Guaranteed Salary | Cap Number | Cap % | Cash Paid | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014 | Lions | $420,000 | $507,655 | $0 | $0 | $0 | $0 | $420,000 | $927,655 | 0.7% | $2,450,620 | ||
| 2015 | Lions | $601,914 | $507,655 | $50,000 | $0 | $0 | $0 | $601,914 | $1,159,569 | 0.8% | $651,914 | ||
| 2016 | Patriots | $758,828 | $0 | $0 | $0 | $0 | $0 | $0 | $446,369 | 0.3% | $446,369 | ||
| 2017 | Patriots | $990,741 | $1,166,666 | $100,000 | $0 | $25,000 | $0 | $0 | $2,282,407 | 1.4% | $4,615,741 | ||
| 2018 | Patriots | $2,000,000 | $1,166,666 | $0 | $500,000 | $0 | $0 | $2,000,000 | $3,572,916 | 2.0% | $2,875,000 | ||
| 2019 | Patriots | $4,250,000 | $1,166,668 | $0 | $500,000 | $0 | $375,000 | $0 | $6,291,668 | 3.2% | $4,750,000 | ||
| 2020 | Dolphins | $3,000,000 | $1,375,000 | $6,500,000 | $0 | $25,000 | $0 | $9,500,000 | $10,900,000 | 5.0% | $15,025,000 | ||
| 2021 | Dolphins | $12,500,000 | $1,375,000 | $0 | $0 | $25,000 | $0 | $0 | $13,900,000 | 6.5% | $12,525,000 | ||
| 2022 | Dolphins | $12,250,000 | $1,375,000 | $0 | $0 | $25,000 | $0 | $0 | $13,650,000 | 6.0% | $12,275,000 | ||
| 2023 | Dolphins | $11,150,000 | $1,375,000 | $0 | $0 | $25,000 | $0 | $0 | $12,550,000 | 5.2% | $11,175,000 | ||
| Total | $47,921,483 | $10,015,310 | $6,650,000 | $1,000,000 | $125,000 | $375,000 | $12,521,914 | $65,680,584 | $66,789,644 | ||||
Statistics
| Year | Games Played | Games Missed | Snaps | Tackles | Negative Plays | Interceptions | Fumbles | TD | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Injured | Healthy | Defense | Special | Solo | Assist | Sacks | Yards | TFL | QB Hits | Pass Def. | INT | Yards | Forced | Rec. | Yards | |||
| 2014 | 8 | 8 | 0 | 4.9% | 29.3% | 6 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2015 | 15 | 0 | 1 | 7.6% | 62.8% | 8 | 2 | 1 | 1 | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2016 | 14 | 0 | 2 | 50.6% | 33.3% | 32 | 20 | 1 | 8 | 2 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 0 |
| 2017 | 13 | 3 | 0 | 66.9% | 16.7% | 58 | 15 | 5.5 | 33.5 | 7 | 9 | 2 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2018 | 16 | 0 | 0 | 90.5% | 28.3% | 55 | 37 | 3.5 | 28 | 5 | 10 | 2 | 1 | 0 | 1 | 2 | 46 | 1 |
| 2019 | 15 | 0 | 1 | 80.5% | 2.2% | 41 | 16 | 6.5 | 42.5 | 7 | 14 | 3 | 0 | 0 | 3 | 2 | 22 | 1 |
Valuation Diamond
The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.
| OTC Valuation | APY | |
|---|---|---|
| Regular | $12,178,000 | $12,750,000 |
| Injury Adjusted | $12,178,000 | $12,750,000 |
test
Weekly Valuation Trends
The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.
To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.